Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Predicting Reaction Outcomes02:24

Predicting Reaction Outcomes

11.0K
Kinetics describes the rate and path by which a reaction occurs. In contrast, thermodynamics deals with state functions and describes the properties, behavior, and components of a system. It is not concerned with the path taken by the process and cannot address the rate at which a reaction occurs. Although it does provide information about what can happen during a reaction process, it does not describe the detailed steps of what appears on an atomic or a molecular level. On the other hand,...
11.0K
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

1.0K
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.0K
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

4.0K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.0K
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

951
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
951
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

395
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
395
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

1.0K
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
1.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Antepartum Transcatheter Patent Foramen Ovale Closure During Pregnancy: A Risk-Based Clinical Perspective.

Circulation reports·2026
Same author

Retrograde Balloon Pulmonary Angioplasty for Otherwise Uncrossable Lesions in Chronic Thromboembolic Pulmonary Hypertension.

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions·2026
Same author

Mortality Impact of Stroke and Major Bleeding Across the Ejection Fraction Spectrum in Patients Hospitalized for Acute Heart Failure With Prevalent Atrial Fibrillation.

Cardiology·2026
Same author

Paroxysmal sympathetic hyperactivity secondary to hypoglycemic encephalopathy: A case report.

Journal of diabetes investigation·2026
Same author

[Surgical Outcomes of Stanford Type A Acute Aortic Dissection in the Patients Aged 85 Years or Above].

Kyobu geka. The Japanese journal of thoracic surgery·2026
Same author

[Extensive Atrial Resection for Marked Atrial Enlargement due to Long-standing Persistent Atrial Fibrillation].

Kyobu geka. The Japanese journal of thoracic surgery·2026

Related Experiment Video

Updated: Feb 13, 2026

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
05:16

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure

Published on: June 10, 2025

661

Risk Stratification and Outcome Prediction in Heart Failure Patients With Cardiac Implantable Electronic Devices

Keijiro Nakamura1, Kazutaka Aonuma2, Torsten Kayser3

  • 1Division of Cardiovascular Medicine, Toho University Ohashi Medical Center Tokyo Japan.

Circulation Reports
|February 12, 2026
PubMed
Summary

Machine learning models accurately predict adverse outcomes in Japanese heart failure patients with cardiac devices. This approach enhances risk stratification and supports personalized treatment strategies for better patient management.

Keywords:
Cardiac resynchronization therapyHeart failureMachine learningRisk stratificationShapley additive explanations (SHAP) analysis

More Related Videos

Author Spotlight: Workflow for Integrating POCUS Data into EHR for Managing Heart Failure Patients
03:47

Author Spotlight: Workflow for Integrating POCUS Data into EHR for Managing Heart Failure Patients

Published on: July 12, 2024

1.2K
Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.9K

Related Experiment Videos

Last Updated: Feb 13, 2026

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
05:16

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure

Published on: June 10, 2025

661
Author Spotlight: Workflow for Integrating POCUS Data into EHR for Managing Heart Failure Patients
03:47

Author Spotlight: Workflow for Integrating POCUS Data into EHR for Managing Heart Failure Patients

Published on: July 12, 2024

1.2K
Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.9K

Area of Science:

  • Cardiology
  • Medical Informatics
  • Machine Learning

Background:

  • Heart failure (HF) prevalence is rising in Japan's aging population.
  • Implantable cardioverter defibrillator and cardiac resynchronization therapy use is lower in Japan compared to Western countries.
  • The HINODE study prospectively collected data on Japanese patients with cardiac devices.

Purpose of the Study:

  • To develop interpretable machine learning (ML) models for improved risk stratification in Japanese HF patients.
  • To identify key predictors of adverse outcomes, including HF hospitalization and all-cause mortality.
  • To support personalized management strategies for HF patients with cardiac devices.

Main Methods:

  • Utilized data from 332 HINODE participants with adequate data.
  • Developed predictive models using XGBoost with 5-fold cross-validation.
  • Employed Shapley Additive Explanations (SHAP) for feature importance and K-means clustering for risk stratification.

Main Results:

  • Models demonstrated strong discrimination for HF events (AUC 0.83) and mortality (AUC 0.85).
  • Key predictors identified included QRS duration, QT interval, left ventricular volumes, and medications.
  • Two distinct risk clusters were identified: low-risk (n=236) and high-risk (n=86), with significantly different event rates.

Conclusions:

  • Interpretable ML models accurately predict risk and enable phenotype-based stratification in Japanese HF patients.
  • Findings support the use of ML for personalized management of HF patients with cardiac devices.
  • This approach can help optimize treatment strategies in this growing patient population.